By Tom Winnifrith | Monday 20 June 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
He might come home with a raft of certificates for "Welsh speaker of the week", or other such academic achievements, but Joshua is no great sportsman. Yet this afternoon, it is the school sports day, and the whole family is off to watch him. Discussing what lies ahead with him as we walked to school this morning, filled me with pride. In the main podcast, I look at Forward Partners (FWD) - another disastrous 2021 IPO; Petropavlovsk (POG), as it races to zero; Genflow Biosciences (GENF); MGC Pharmaceuticals (MXC) - placing ahoy; and Verditek (VDTK), where things could get very messy within days. Ref MXC, I discuss two historic examples of biotech's presenting data - on AIDS "cures", and its spoof ramp last week.
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.
Filed under:
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Time left: 11:26:56